UKAPTB Network Meeting 2024 - Strengthening partnerships across the UK to end TB

Strengthening partnerships across the UK to end TB

Welcome to the first UKAPTB all-members in-person meeting in Liverpool on Friday 26 January

The UK Academics and Professionals to end TB (UKAPTB) network brings together UK-based academics and professionals with an interest in TB to accelerate progress to a TB-free world.

The network primarily campaigns, advocates, and educates the public servants, politicians, and the public to improve UK policies on TB and devote more resources to TB research.

The aim of this first in-person meeting is to keep the momentum and energy from the United Nations High Level Meeting on the Fight Against TB in 2023 to ensure that we are partnering effectively both in the UK and globally across disciplines, stakeholders, and sectors to follow through on commitments and contribute as best we can to ending TB by 2030.

We look forward to an insightful day of knowledge sharing with plenty of opportunities to connect with other UK TB stakeholders:

  • tuberculosis researchers

  • health professionals

  • civil society

  • affected communities

  • and other stakeholders all working on tuberculosis.


We look forward to you joining us at Spaces at the Spine in Liverpool on the 26th!

Navigate to:

Agenda


Friday 26th January

Lunch

Speaker Affiliations and Bios

 

Isa Ahmad

Imperial College London

~~~~

Lynn Altass

Senior Programme Manager, TB, NHS England

~~~~

Samara Barnes

TB Survivor

~~~~

Charlotte Clayton

TB Specialist Nurse, Liverpool University Hospitals NHS Foundation Trust

~~~~~

Gerry Davies

Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital

~~~~~

Martin Dedicoat

Consultant in Infectious Diseases, TB Unit, UK Health Security Agency

~~~~~

Hannah Monica Dias

Cross-Cutting Lead, Strategic Leadership and Multisectoral Engagement, Global TB Programme, WHO

~~~~~

Pete Dodd

University of Sheffield

~~~~~

Hanif Esmail

Clinical Associate Professor in Infectious Diseases, University College London

~~~~~

Janika Hauser

Campaigns in Global Health

~~~~~

Rt Hon Lord Herbert of South Downs

Co-Chair Global TB Caucus

~~~~~

Gwen Knight

Associate Professor and co-Director of the AMR Centre, London School of Hygiene & Tropical Medicine

~~~~~

Marc Lipman

University College London

~~~~~

Peter MacPherson

University of Glasgow

~~~~~

Adrian Martineau

Queen Mary University of London

~~~~~

 

Kerry Millington

London School of Hygiene & Tropical Medicine & Co-Chair UKAPTB

~~~~~

Sarah Murphy

Clinical Lead TB Nurse Specialist, Kent Community Health NHS Foundation Trust

~~~~~

Morris Muzyamba

Healthcare Scientist, TB Team, Public Health Scotland

~~~~~

Jessica Potter

North Middlesex University Hospital Trust, University College London & Co-Chair UKAPTB

~~~~~

Mr Virendra Sharma

TB All-Party Parliamentary Group

~~~~~

Emily Shaw

University College London Hospital NHS Trust

~~~~~

Bertie Squire

Dean of Clinical Sciences & International Public Health, Liverpool School of Tropical Medicine

~~~~~

Surinder Tamne

Senior Nurse, TB Unit, UK Health Security Agency

~~~~~

Yami Torbieu

Policy and Programme Officer, Diseases of Poverty Malaria, TB & NTDs, Foreign, Commonwealth & Development Office

~~~~~

Anna Trelfa

Consultant in Health Protection, Greater Manchester Health Protection Team, UK Health Security Agency

~~~~~

Naomi Walker

Senior Clinical Lecturer at Liverpool School of Tropical Medicine and NHS Consultant in Infectious Diseases and General Medicine, Liverpool University Hospitals NHS Foundation Trust

~~~~~

Richard White

Professor of Infectious Disease Modelling, London School of Hygiene & Tropical Medicine

~~~~~

Tom Wingfield

Liverpool School of Tropical Medicine

~~~~~

Vinny Wooding

Results UK

~~~~~

Isa Ahmad

I am a PhD student at Imperial College London undertaking research in tuberculosis epidemiology. My project is focused on mathematical modelling of tuberculosis in England, and ultimately defining a cost-effective contact tracing scheme for TB. My background is in mathematics and epidemiology. Prior to my PhD I worked as a research assistant in investigating the barriers to entry into the influenza vaccine market.

 

Lynn Altass

Lynn Altass has worked in TB since 2003 and previously in research, hospital management, commissioning and public health. With UKHSA, she co-authored the TB Action Plan for England, 2021 to 2026. Her main focus is ensuring delivery of the latent TB testing and treatment programme for NHS England plus supporting TB services and commissioners to provide TB services that best meet patients’ needs. Current work in 2023/24 includes the ‘Get It Right First Time’ (GIRFT) TB Project which works to the principle that a patient should expect to receive equally timely and effective investigations, treatment and outcomes wherever care is delivered, irrespective of who delivers that care.

Samara Barnes

Samara Barnes was diagnosed with active pulmonary TB in late 2015 and it was discovered she was also drug resistant a little while into her treatment. Until that point, Samara knew little about the illness apart from the fact that her Grandad had died of TB many years previously. She is now Affected Community co-lead on the Executive Committee of the UK Academics and Professionals to end TB network. It is important for Samara to raise awareness of this illness, be an advocate for reducing the stigma surrounding it and to encourage decision makers in the UK to ensure they keep to their commitment of a year-on-year reduction of TB and contribute to the WHO's commitment to eliminate TB by 2035. 

Charlotte Clayton

Charlotte has been a Tuberculosis Specialist Community Nurse in Liverpool for the past year, with previous experience in various hospital wards, including Infectious Diseases at the Royal Liverpool Hospital. She has a keen interest in Infectious Diseases and Inclusion Health which led her to complete the Diploma of Tropical Nursing at Liverpool School of Tropical Medicine in 2021.

Gerry Davies

Gerry is Professor of Infection Pharmacology and Consultant in Infectious Diseases at the University of Liverpool. He ran a district TB programme in South Africa from 1994-1998, subsequently conducting TB research in Thailand, Peru and Malawi. He is TB clinical lead for Liverpool and participates in the BTS MDR-TB Advice Service. He is a Cochrane editor, specialising in TB and has extensive experience of TB clinical trials. Since 2012 he served on numerous WHO policy taskforces and guidelines development groups.

Martin Dedicoat

Martin Dedicoat is TB clinical lead for Birmingham and Solihull, Infectious diseases consultant in the TB Unit UKHSA and at University Hospitals Birmingham NHS Trust.

Hannah Monica Dias

Hannah Monica Dias leads the work at the World Health Organization (WHO) Global Tuberculosis Programme on advancing multisectoral engagement and accountability, including engaging sectors beyond health to address the key drivers of the TB epidemic and strengthening public-private sector partnerships. She coordinates the WHO Flagship Initiative on ending TB – that focuses on accelerating universal access to quality, WHO-recommended TB prevention and care, advancing research especially into new TB vaccines, strengthening engagement and accountability across sectors beyond health, and on linkages to the broader health agendas on antimicrobial resistance, universal health coverage and pandemic preparedness. Her scope of work includes the development of innovative policies and strategies including on TB elimination and public-private mix, high level advocacy and knowledge sharing, mobilising key stakeholders including youth and civil society, and support to countries in adapting and implementing key guidance including WHO’s Multisectoral Accountability Framework. Prior to joining WHO, she worked at the International Trade Centre in Geneva on HIV and trade, as well as at a private non-profit hospital in Mumbai, India. She holds a Master’s degree in Business Administration (MBA) from the University of Mumbai in India; and a Master’s degree in International Health Policy from the London School of Economics.

Pete Dodd

Pete Dodd is a professor of mathematical modelling and epidemiology, originally trained in mathematics (Cambridge) and theoretical physics (Imperial College London). He held postdocs in infectious disease modelling at Imperial and the LSHTM, before moving to Sheffield. Pete is interested in developing modelling and statistical methods to better understand tuberculosis burden and epidemiology, and to interpret and evaluate interventions. He is particularly interested in systematic screening for tuberculosis, and interventions to improve detection and management of paediatric tuberculosis.

Hanif Esmail

Clinical Associate Professor in Infectious Diseases, University College London

Janika Hauser

Janika Hauser is a director of Campaigns in Global Health, an NGO focused on policy engagement and advocacy to bring better health to everyone. Prior to joining CGH, she acted as policy manager at a royal medical college, a policy advisor to an APPG, and worked with civil society and affected communities on TB and global health R&D. She holds a BA in international relations from Exeter and focused her MSc at Aarhus University on MDR-TB policy uptake, conducting research with the WHO Global TB Programme. 

Rt Hon Lord Herbert of South Downs

Nick Herbert is the founder and Chair of the Global TB Caucus and has been involved globally in the fight against TB for nearly two decades. He is a Member of the House of Lords in the United Kingdom Parliament.  

Gwen Knight

Dr Gwen Knight is an Associate Professor and co-Director of the AMR Centre at the London School of Hygiene and Tropical Medicine. She uses mathematical modelling and interdisciplinary data analysis to answer questions around the dynamics of antibiotic resistance in key pathogens such as S. aureus and M. tuberculosis. She currently holds an MRC Career Development Award to explore how AMR prevalence in infection varies by age and sex.

Marc Lipman

Marc Lipman is Professor of Medicine at UCL and Honorary Consultant in Respiratory and HIV Medicine at the Royal Free Hospital. He is Director of UCL-TB, which is linked to the UCL WHO Collaborating Centre for TB. He chairs the UK Joint TB Committee, and NTM Network UK, the country’s largest NTM clinical research group. He is UKAPTB’s Executive Committee Clinical Lead. Marc’s research focuses on improving patient outcomes and healthcare delivery.

Peter MacPherson

Peter MacPherson is Professor of Global Public Health at the School of Health & Wellbeing, University of Glasgow, Honorary Professor at the London School of Hygiene and Tropical Medicine, and Honorary Consultant in Communicable Disease Control with Public Health Scotland. He trained in Medicine at Aberdeen University, did Masters degrees at Harvard and University of Liverpool, and his PhD at the Liverpool School of Tropical Medicine. Prior to joining the University of Glasgow in January 2023, Peter was Wellcome Fellow and Head of the Public Health Research Group at the Malawi-Liverpool-Wellcome Programme in Blantyre Malawi. His research focuses on the design and evaluation of interventions to improve the diagnosis of tuberculosis, particularly in communities and primary care.

Adrian Martineau

Adrian is Clinical Professor of Respiratory Infection at Queen Mary University of London. The current major focus of his lab is on development of a molecular microbial blood test for M. tuberculosis infection.

Kerry Millington

Dr Kerry Millington is Director of the Liverpool School of Tropical Medicine (LSTM) Centre for Tuberculosis Research. She has worked in academia for nearly 20 years, including at the University of Oxford and Imperial College London.  At LSTM, Dr Millington has worked on the K4D and HEART programmes, supporting the use of learning and evidence to improve the impact of development policy and programmes, and currently works to maximise research impact through the LIGHT Consortium, which aims to transform gendered pathways to health for tuberculosis. She co-Chair’s the UK Academics and Professionals to end TB (UKAPTB) network.

Sarah Murphy

Sarah is the Clinical Lead TB Nurse Specialist in Kent Community Healthcare Foundation Trust. She has been a TB Nurse Specialist for over 16 years working in a variety of clinical and public health roles. She has worked in London services, National UKHSA TB Unit and more recently in Kent. She was the Lead Nurse for the innovative London TB Extended Contact Screening Project (LTBEx) for which she won RCN’s Public Health Nurse Award. @tb_or_not_tb_uk .

Morris Muzyamba

Morris Muzyamba is an epidemiologist currently working at Public Health Scotland. He initially worked in biomedical research before doing an MSc in epidemiology at the University of London. Morris has over 10 years’ experience of working in public health having previously worked in healthcare associated infections and tuberculosis (TB) at UKHSA. Previous work in TB included working in UK pre-entry TB screening, latent TB infection and TB surveillance. His current interests include in tuberculosis and inequalities, and zoonotic TB.

Jessica Potter

Dr Jess Potter is a clinician, researcher and activist. She works as a consultant in respiratory medicine and lead of the TB service in a busy London hospital. She is co-chair of UK Academics and Professionals to end TB. Jess is a qualitative researcher with an interest in the structural determinants of healthcare access. She campaigns for the healthcare rights of migrants and to increase TB awareness with a range of organisations and has written about these issues in the national and international press.

Virendra Sharma

Virendra Sharma is the Member of Parliament for Ealing Southall, having served since 2007. In Parliament he campaigns on equality, transport, healthcare, and international development, as well as sitting on the International Development Select Committee, Parliamentary Assembly of the Council of Europe, and Panel of Chairs. A long career in local government as Councillor and Mayor, and work on busses, London Underground and care sector preceded his time in Parliament, as did his time as National BAME Officer for the Labour Party for the 1987 and 1992 General Elections. Alongside local campaigns, Virendra chairs the Indo-British, Nepal, TB and Population Development and Reproductive Health All-Party Parliamentary Groups and speaks regularly on those issues.

Emily Shaw

Dr Emily Shaw is an Infectious Diseases Consultant with a joint appointment at University College London Hospitals and the UKHSA National Tuberculosis Unit. She trained in London and has delivered TB care in high-burden settings, including for the Medecins Sans Frontieres MDR-TB programme in Uzbekistan. Her Wellcome UCL PhD was in BCG vaccinology, and she is a member of UCL-TB. Dr Shaw works with Find and Treat piloting the delivery of LTBI care in HM Prisons and Immigration Removal Centres.

Professor Bertie Squire

Bertie Squire is Professor of Clinical Tropical Medicine & Dean of Partnerships, at the Liverpool School of Tropical Medicine (LSTM) and Consultant Physician in Infectious Diseases and Tropical Medicine at the Royal Liverpool University Hospital.  In his role as Dean at LSTM he has been at the forefront of complex organizational change, leading the development of this international Higher Education Institution’s new partnership strategy. He is Research Director of the UKAID-funded LIGHT and the UNITAID-funded Start4ALL Consortia.

He has a strong track record of leadership, including at board level, of public and voluntary international organisations. His passion for international development and foreign policy work is demonstrated by a 28-year record of managing of large, multi-country programmes of multi-disciplinary health research aimed at providing knowledge for action in making health services more accessible to poor and vulnerable people, particularly those with TB. He served as the elected President of the International Union Against TB & Lung Disease (IUATLD) 2008-2011, was a member of the World Health Organisation (WHO) Strategic and Technical Advisory Group for Tuberculosis and is currently a member of the UNICEF, UNDP, World Bank, and WHO-sponsored Special Programme for Research & Training in Tropical Diseases (TDR) Strategic and Technical Advisory Committee.

Surinder Tamne

Surinder. K Tamne is a Senior Nurse and has worked as Lead TB Nurse for 15 years in UKHSA TB Unit. She is an advocate for holistic care, nursing workforce development and early collaboration supporting a system thinking approach to facilitate equitable care that is patient centric. She is passionate about seeing greater nurse leadership and involvement within the innovation ecosystem, working to collaborate with all partners transforming strategy into action in a timelier way.

Yami Torbieu

Yami Torbieu is a Policy Officer in the Global Health and Institutions Department in the Foreign Commonwealth and Development Office (FCDO).  We support the development of policy on the three diseases: Malaria, Tuberculosis (TB) and Neglected Tropical Diseases (NTDs) and work closely with the APPG on Global TB; have strong collaboration with Stop TB Partnership & Results UK.  Our £1bn support to the Global Fund supports ending malaria, tuberculosis, and HIV&AIDS.  We also support TB REACH programmes which deploy innovative approaches to improve surveillance and detection of TB.

Anna Trelfa

Dr Anna Trelfa is a Consultant in Health Protection with the Greater Manchester Health Protection Team (GM HPT), UK Health Security Agency Northwest. She is the GM HPT strategic lead for Tuberculosis and has demonstrated a commitment to partnership working and collaboration as the chair of the Greater Manchester TB Collaborative – a multi-agency group that develops and implements the regional TB control strategy. She is also the GM HPT strategic lead for Surveillance, and the Research lead for the UKHSA Northwest region.

Dr Naomi Walker -

PhD MRCP DTM&H

 Senior Clinical Lecturer in Experimental Medicine, Liverpool School of Tropical Medicine (LSTM); Consultant in Infectious Diseases and General Internal Medicine, Liverpool University Hospitals NHS Foundation Trust.

Naomi is a clinical academic based at Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust. Her research is focus is on TB disease, understanding poor outcomes and identifying interventions to reduce morbidity. She is a member and co-chair of the Liverpool TB multidisciplinary team.

https://www.lstmed.ac.uk/about/people/dr-naomi-walker

Richard White

Richard White is Professor of Infectious Disease Modelling in the Centre for the Mathematical Modelling of Infectious Diseases, the TB Centre, and the Vaccine Centre at the London School of Hygiene and Tropical Medicine. He is Director of the TB Modelling and Analysis Consortium (TB MAC) and co-leads the LSHTM TB Modelling Group with Rein Houben. Richard's research focus is the mathematical and statistical modelling of the transmission and control of infectious diseases, particularly TB and HIV.

Tom Wingfield

Tom is an infectious diseases physician and Reader (ORCID ID 0000-0001-8433-6887) at Liverpool School of Tropical Medicine, UK, and Karolinska Institutet, Sweden. He has a special interest in addressing the social determinants and consequences of TB and poverty-related diseases. Tom has worked clinically and/or in research in UK, sub-Saharan Africa, Latin America, and South East Asia.

He is a co-founder and active member of the international social protection network “SPARKS”, leads the LIV-TB cross-campus TB research and education collaboration, and is Deputy Director of the new “LSTM Centre for Tuberculosis Research” formed in 2024. Tom is PI of the ASCOT trial of socioeconomic support for people with TB in Nepalfunded by the Medical Research Council, UK, co-PI with Dr Celso Khosa on the SAFEST-MDR-TB-1 study examining the acceptability and feasibility of video-observed therapy (VOT) in Mozambique funded by the Medical Research Foundation, UK, and co-PI with Dr Ahmad Fuady of the TB-CAPS study to co-develop, implement, and evaluate a psychosocial support intervention to reduce stigma amongst people with TB in Indonesia. Tom is implementation lead on the UNITAID-funded Start 4 All consortium examining novel TB diagnostics and diagnostic combinations and pathways to find the missed millions.

Vinny Wooding

Vinny Wooding serves as Secretary and Treasurer on the Executive Committee of UK Academics and Professionals to end TB. His is a Senior Parliamentary Advocacy Officer for TB and serves as the coordinator of the All-Party Parliamentary Group for Tuberculosis. Before joining RESULTS UK, Vinny worked for the Chair of the International Development Select Committee, Homes England, and the Labour Party.

Our Hosts

 

Liverpool School of Tropical Medicine (LSTM) has been at the forefront of research into infectious, debilitating, and disabling diseases since 1898with an overall mission to improve health outcomes in disadvantaged populations globally.

Our research continues to improve the health of the world's poorest people, with a research portfolio of around £220 million and projects and partnerships in more than 70 countries. The newly created Centre for Tuberculosis Research aims to improve health, social and economic outcomes for people affected by TB through LSTM’s overall approach of research, partnership and education.

Venue Address

 

Spaces at the Spine, 2 Paddington Village, Liverpool, L7 3FA

 

Hashtags for X (previously twitter)

 

Hashtags

!!More Coming Soon!!

#UKAPTB2024

#EndTB

Institutes

@UKAPTB

@LSHTM_TB

@LIGHTonTB

@CGHProject

@resultsuk

@LivUni

@LSTMnews

@UCLGlobalHealth

@UofGlasgow

Previous
Previous

Strengthening partnerships across the UK to end TB through a UKAPTB Network Meeting

Next
Next

The Good The Bad and The Ugly: A UN High-level meeting on Tuberculosis retrospective